March 14, 2000; 54 (5) Articles
Cladribine and progressive MS
Clinical and MRI outcomes of a multicenter controlled trial
George P. A. Rice, Massimo Filippi, Giancarlo Comi, for the Cladribine Clinical Study Group and for the Cladribine MRI Study Group*
First published March 14, 2000, DOI: https://doi.org/10.1212/WNL.54.5.1145
George P. A. Rice
Massimo Filippi
Cladribine and progressive MS
Clinical and MRI outcomes of a multicenter controlled trial
George P. A. Rice, Massimo Filippi, Giancarlo Comi, for the Cladribine Clinical Study Group and for the Cladribine MRI Study Group*
Neurology Mar 2000, 54 (5) 1145-1155; DOI: 10.1212/WNL.54.5.1145
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 54 no. 5 1145-1155
PubMed:
Print ISSN:
Online ISSN:
History:
- Received June 10, 1999
- Accepted November 1, 1999
- First Published March 14, 2000.
Copyright & Usage:
© 2000
Author Disclosures
- George P. A. Rice, MD,
- Massimo Filippi, MD,
- Giancarlo Comi, MD and
- for the Cladribine Clinical Study Group and for the Cladribine MRI Study Group**
- George P. A. Rice, MD,
- Massimo Filippi, MD,
- Giancarlo Comi, MD and
- for the Cladribine Clinical Study Group and for the Cladribine MRI Study Group**
- From the University Hospital (Dr. Rice)University of Western Ontario, London, Canada; and the Neuroimaging Research Unit (Dr. Filippi) and Clinical Trials Unit (Dr. Comi), Department of Neuroscience, Scientific Institute Ospedale San Raffaele, University of Milan, Italy.
- Address correspondence and reprint requests to Dr. Rice, LHSC-UC, 339 Windermere Road, London, Ontario N6A 5A5, Canada; e-mail: grice{at}julian.uwo.ca
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan
Related Articles
- No related articles found.